Relation of poor sleep quality to resistant hypertension
American Heart Association News Tip - Abstract 63
September 21, 2012
EMBARGOED UNTIL 3:45 pm ET, Friday, September 21, 2012
WASHINGTON, DC, September 21, 2012 - For people who already have high blood pressure, insomnia can have serious consequences, according to a new study presented at the American Heart Association’s High Blood Pressure Research 2012 Scientific Sessions.
Researchers studied the sleeping patterns of 234 people with high blood pressure. Most participants slept six or fewer hours, and those who also reported poor sleep quality were twice as likely to have resistant hypertension as those who slept well.
Your blood pressure is considered resistant if you are taking three or more blood pressure medications but still have a blood pressure reading higher than 140/90 mmHg.
Women were more likely to report lower sleep quality than men. The researchers concluded that those with high blood pressure were more likely to have sleep problems, and poor sleep quality in high blood pressure patients was associated with resistant hypertension. More study is needed to clarify the cause.
The study was funded by the University of Pisa.
Note: Scientific presentation is at 3:45 p.m. ET, Friday, September 21, 2012
Author disclosures are on the abstracts.
For the latest heart and stroke news, follow us on twitter: @HeartNews .
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding .
Additional resources, including multimedia, are available in the right column.
For media inquiries: (214) 706-1173
Audrey Ward: (214) 706-1166; firstname.lastname@example.org
Darcy Spitz: (212) 878-5940; Darcy.Spitz@heart.org
Julie Del Barto (broadcast): (214) 706-1330; Julie.DelBarto@heart.org
For public inquiries: (800) AHA-USA1 (242-8721)